Brookfield Corp’s Ingevity NGVT Stock Holding History

Brookfield Corp’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-28,093	Closed	-$1.48M	–	432
2020 Q2	$1.48M	Buy	+28,093	New	+$1.33M	0.01%	255

Other funds holding NGVT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBCM

Broad Bay Capital Management New York $1.07B AUM 90.15% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Brookfield Corp's NGVT Position: Q3 2020 in Review

Brookfield Corp sold out of Ingevity (NGVT) in Q3 2020, closing a stake of 28,093 shares — an estimated $1.48M sold.

Brookfield Corp first reported a position in NGVT in Q2 2020 and held it in 1 quarter. The position peaked at $1.48M in Q2 2020. 283 funds tracked by Wall St. Rank hold NGVT as of Q3 2020.

Brookfield Corp reported no remaining Ingevity position as of Q3 2020 after selling out during the quarter.
Brookfield Corp sold 28,093 Ingevity shares in Q3 2020, an estimated $1.48M.
Brookfield Corp first reported a position in Ingevity in Q2 2020 and held it in 1 quarter.
Brookfield Corp's Ingevity position peaked at $1.48M in Q2 2020.
283 funds tracked by Wall St. Rank held Ingevity as of Q3 2020.

Based on Brookfield Corp's 13F filing for Q3 2020, filed 16 Nov 2020.